|Last Price||Today's Change||52-Week Range||Trading Volume|
|67.85||-0.23 (-0.34%)||51.82 - 70.54||1.4 million (Below Avg)|
Market data as of 1:01PM 11/27/15. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb Announces U.S. Food and Drug Administration Approval for Opdivo (nivolumab) as a Single Agent for the Treatment of Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma
11/24/2015 6:55 AM ET